Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Peptidylarginine deiminase and protein citrullination in prion diseases: Strong evidence of neurodegeneration.
Neuromyelitis optica spectrum disorder as a paraneoplastic manifestation of lung adenocarcinoma expressing aquaporin-4.
Lhermitte's Sign: The Current Status.
An 8-Year-Old Boy With Ascending Paralysis.
Solifenacin is effective and well tolerated in patients with neurogenic detrusor overactivity: Results from the double-blind, randomized, active- and placebo-controlled SONIC urodynamic study.
Pertussis toxin modulates microglia and T cell profile to protect experimental autoimmune encephalomyelitis.
Natalizumab Continued Past 24 Months Safely in MS
Quantitative texture analysis of brain white matter lesions derived from T2-weighted MR images in MS patients with clinically isolated syndrome.
[Microglia in pathophysiology of neuroimmunological disorders].
Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis.
How do immune cells support and shape the brain in health, disease, and aging?
Acute disseminated encephalomyelitis, transverse myelitis, and neuromyelitis optica.
Novel Kv1.3 blockers for immunosuppression: W02012155199.
Cerebral white matter disease in patients with malignancy: pml versus toxic leucoencephalopathy due to chemotherapy.
Erratum to: Promoting Remyelination in Multiple Sclerosis-Recent Advances.
Functional Homotopic Changes in Multiple Sclerosis with Resting-State Functional MR Imaging.
Intense inflammation and nerve damage in early multiple sclerosis subsides at older age: a reflection by cerebrospinal fluid biomarkers.
Emerging roles of system [Formula: see text] antiporter and its inhibition in CNS disorders.
A concise synthesis of Fingolimod: an orally available drug for treating multiple sclerosis.
Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study.
Elevated Neutrophil Lymphocyte Ratio in Recurrent Optic Neuritis.
Vitamin D and multiple sclerosis.
Multiple sclerosis susceptibility in a Brazilian sample, HLA and CIITA genes.
Early brain pseudoatrophy while on natalizumab therapy is due to white matter volume changes.
An observational, retrospective, UK and Ireland audit of patient adherence to subcutaneous interferon beta-1a injections using the RebiSmart(®) injection device.
Pages
« first
‹ previous
…
349
350
351
352
353
354
355
356
357
…
next ›
last »